NEELS GUIDO J — SEC insider filings

SEC reporting owner CIK 1222362. 29 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 29 filings on record, filed 2020-09-08 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Axogen, Inc. (AXGN)Director111 leg · 10,000 sh · $61,1001 leg · 4,073 sh · $43,21525
ELUTIA INC. (ELUT)Director73 legs · 50,000 sh · $52,600—7
Bioventus Inc. (BVS)Director10——19
TELA Bio, Inc. (TELA)Director1——4

Insider filings — NEELS GUIDO J

FiledFormIssuerReported transactionsSource
2026-11-124ELUTIA INC. (ELUT)Grant/award (A): 117,000 (derivative) @ $0EDGAR
2026-06-154ELUTIA INC. (ELUT)Grant/award (A): 106,393 (derivative) @ $0EDGAR
2026-06-114TELA Bio, Inc. (TELA)Grant/award (A): 11,925 @ $0 · Grant/award (A): 11,675 @ $0 · Grant/award (A): 17,550 (derivative) @ $0 · Grant/award (A): 17,335 (derivative) @ $0EDGAR
2026-06-044Bioventus Inc. (BVS)Option exercise (M): 32,282 @ $0 · Option exercise (M): 32,282 (derivative) @ $0 · Grant/award (A): 25,146 (derivative) @ $0EDGAR
2026-04-144ELUTIA INC. (ELUT)Option exercise (M): 6,250 · Option exercise (M): 6,250 (derivative) @ $0EDGAR
2026-02-024ELUTIA INC. (ELUT)Purchase (P): 20,000 @ $1.04EDGAR
2026-01-294ELUTIA INC. (ELUT)Purchase (P): 15,000 @ $1.06 · Purchase (P): 15,000 @ $1.06EDGAR
2025-12-024ELUTIA INC. (ELUT)Option exercise (M): 6,250 · Option exercise (M): 6,250 (derivative) @ $0EDGAR
2025-10-144ELUTIA INC. (ELUT)Grant/award (A): 171,916 (derivative) @ $0EDGAR
2025-06-114Axogen, Inc. (AXGN)Sale (S): 4,073 @ $10.61EDGAR
2025-06-044Bioventus Inc. (BVS)Option exercise (M): 26,493 @ $0 · Option exercise (M): 26,493 (derivative) @ $0 · Grant/award (A): 32,282 (derivative) @ $0EDGAR
2024-09-044Axogen, Inc. (AXGN)Option exercise (M): 11,904 @ $0 · Option exercise (M): 11,904 (derivative) @ $0EDGAR
2024-06-134Bioventus Inc. (BVS)Grant/award (A): 26,493 (derivative) @ $0EDGAR
2024-06-114Bioventus Inc. (BVS)Option exercise (M): 30,400 @ $0 · Option exercise (M): 30,400 (derivative) @ $0EDGAR
2024-06-104Axogen, Inc. (AXGN)Grant/award (A): 10,653 · Grant/award (A): 18,248 (derivative) @ $0EDGAR
2023-09-074Axogen, Inc. (AXGN)Grant/award (A): 20,436 (derivative) @ $0 · Grant/award (A): 11,904 (derivative) @ $0EDGAR
2023-08-184Axogen, Inc. (AXGN)Purchase (P): 10,000 @ $6.11EDGAR
2023-06-084Bioventus Inc. (BVS)Option exercise (M): 16,648 @ $0 · Option exercise (M): 16,648 (derivative) @ $0 · Grant/award (A): 30,400 (derivative) @ $0EDGAR
2023-06-054Axogen, Inc. (AXGN)Option exercise (M): 6,459 @ $0 · Option exercise (M): 6,459 (derivative) @ $0EDGAR
2022-06-224Bioventus Inc. (BVS)Grant/award (A): 16,648 (derivative) @ $0EDGAR
2022-06-034Axogen, Inc. (AXGN)Option exercise (M): 3,036 @ $0 · Option exercise (M): 3,036 (derivative) @ $0 · Grant/award (A): 11,811 (derivative) @ $0 · Grant/award (A): 6,459 (derivative) @ $0EDGAR
2022-04-054Bioventus Inc. (BVS)Option exercise (M): 2,700 · Option exercise (M): 2,700 (derivative) @ $0EDGAR
2022-02-154Bioventus Inc. (BVS)Option exercise (M): 9,000 · Option exercise (M): 9,000 (derivative) @ $0EDGAR
2021-06-074/AAxogen, Inc. (AXGN)Option exercise (M): 25,000 @ $3.80 · Option exercise (M): 15,000 @ $5.09 · Option exercise (M): 25,000 (derivative) @ $3.80 · Option exercise (M): 15,000 (derivative) @ $5.09EDGAR
2021-06-034Axogen, Inc. (AXGN)Option exercise (M): 6,173 @ $0 · Option exercise (M): 6,173 (derivative) @ $0 · Grant/award (A): 6,030 (derivative) @ $0 · Grant/award (A): 3,036 (derivative) @ $0EDGAR
2021-05-214Axogen, Inc. (AXGN)Option exercise (M): 25,000 @ $3.80 · Option exercise (M): 15,000 @ $5.09 · Option exercise (M): 25,000 (derivative) @ $3.80 · Option exercise (M): 15,000 (derivative) @ $5.09EDGAR
2021-04-054Bioventus Inc. (BVS)Grant/award (A): 2,700 (derivative) @ $0EDGAR
2021-02-164Bioventus Inc. (BVS)Grant/award (A): 9,000 (derivative) @ $0EDGAR
2020-09-084Axogen, Inc. (AXGN)Grant/award (A): 2,591 @ $11.75EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1222362 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs